• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by AdaptHealth Corp.

    11/13/24 9:30:46 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care
    Get the next $AHCO alert in real time by email
    SC 13G 1 ef20038552_sc13g.htm SC 13G
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549



    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
     
    (Amendment No.)*
     
    AdaptHealth Corp.
    (Name of Issuer)
     
    Class A Common Stock
    (Title of Class of Securities)
     

    00653Q102
     
    (CUSIP Number)
     
     
    September 30, 2024
    (Date of Event Which Requires Filing of this Statement)
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
      ☒
    Rule 13d-1(b)
     
      ☐
    Rule 13d-1(c)
     
      ☐
    Rule 13d-1(d)
     
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Exchange Act”) or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).
     


    CUSIP No. 00653Q102
    13G
     

    1
    NAMES OF REPORTING PERSONS
     
     
    Jefferies LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     

     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    6,764,849 (1) (see Item 4)
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    6,764,849 (1) (see Item 4)
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    6,764,849 (1) (see Item 4)
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    5.0% (2) (see Item 4)
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    BD
     
     
     
     

    (1)
    Reported shares are held by Jefferies LLC. Jefferies LLC is a wholly owned direct subsidiary of Jefferies Financial Group Inc. Comprised of (i) 1,764,449 shares of common stock, par value $0.0001 per share (“Common Stock”), of AdaptHealth Corp. (the “Issuer”), and (ii) 5,000,400 shares of Common Stock purchasable upon exercise of 50,004 exchange-traded long call options (“Options”) that are currently exercisable. Each Option is exercisable for 100 shares of Common Stock.
    (2)
    Based on 134,554,889 shares of Common Stock outstanding as of November 1, 2024, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 5, 2024.

    2

    CUSIP No. 00653Q102
    13G
     

    1
    NAMES OF REPORTING PERSONS
     
     
    Jefferies Financial Group Inc.
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     

     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    New York
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    6,764,849 (1) (see Item 4)
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    6,764,849 (1) (see Item 4)
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    6,764,849 (1) (see Item 4)
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    5.0% (2) (see Item 4)
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    HC
     
     
     
     

    (1)
    Reported shares are held by Jefferies LLC. Jefferies LLC is a wholly owned direct subsidiary of Jefferies Financial Group Inc. Comprised of (i) 1,764,449 shares of Common Stock, and (ii) 5,000,400 shares of Common Stock purchasable upon exercise of 50,004 Options. Each Option is exercisable for 100 shares of Common Stock.
    (2)
    Based on 134,554,889 shares of Common Stock outstanding as of November 1, 2024, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 5, 2024.

    3

    Item 1(a).
    Name of Issuer:
     
    AdaptHealth Corp. (the “Issuer”)
     
    Item 1(b).
    Address of Issuer’s Principal Executive Offices:
     
    220 West Germantown Pike, Suite 250
     
    Plymouth Meeting, PA 19462
     
    Item 2(a).
    Name of Person Filing:
     
    Jefferies LLC
    Jefferies Financial Group Inc.
    (each a “Reporting Person” and collectively, the “Reporting Persons”)
    An agreement among the Reporting Persons that this Schedule 13G is filed on behalf of each of them is attached hereto as Exhibit 1.

    Item 2(b).
    Address of Principal Business Office or, if None, Residence:
     
    520 Madison Ave., New York, NY 10022
     
    Item 2(c).
    Citizenship:
     
    The responses of the Reporting Persons to Row 4 in each of their respective cover pages are incorporated herein by reference.
     
    Item 2(d).
    Title and Class of Securities:
     
    Common Stock, par value $0.0001 per share
     
    Item 2(e).
    CUSIP Number:
     
    00653Q102
     
    Item 3.
    If This Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c), Check Whether the Person Filing is a:
     

    (a) ☒ Broker or dealer registered under Section 15 of the Exchange Act
      (b) ☐ Bank as defined in Section 3(a)(6) of the Exchange Act
      (c) ☐ Insurance company as defined in Section 3(a)(19) of the Exchange Act
      (d) ☐ Investment company registered under Section 8 of the Investment Company Act
      (e) ☐ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E)
      (f) ☐ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F)
      (g) ☒ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G)
      (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act
      (i) ☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act
      (j) ☐ A non-U.S. institution in accordance with Rule 13d–1(b)(1)(ii)(J)
      (k) ☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(K)
     
    If filing as a non-U.S. institution in accordance with Rule 13d–1(b)(1)(ii)(J), please specify the type of institution:
     
    4

    Item 4.
    Ownership.
     
    (a)-(c) The responses of the Reporting Persons to Rows 5, 6, 7, 8, 9 and 11 in each of their respective cover pages which relate to the beneficial ownership of Common Stock, as of September 30, 2024, are incorporated herein by reference.
     
    As of September 30, 2024, the Reporting Persons beneficially owned 6,764,849 shares of Common Stock comprised of (i) 1,764,449 shares of Common Stock, and (ii) 5,000,400 shares of Common Stock purchasable upon exercise of 50,004 Options that are currently exercisable, each of which is exercisable for 100 shares of Common Stock, representing approximately 5.0% of the Common Stock outstanding (based on 134,554,889 shares of Common Stock outstanding as of November 1, 2024, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 5, 2024).
     
    Item 5.
    Ownership of Five Percent or Less of a Class.
     
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the Common Stock, check the following ☐.
     
    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.
     
    Not applicable.
     
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
     
    Jefferies LLC is a broker or dealer registered under Section 15 of the Exchange Act.  Jefferies LLC is a subsidiary of Jefferies Financial Group Inc., which has filed this Schedule 13G pursuant to Rule 13d‑1(b)(1)(ii)(G).
     
    Item 8.
    Identification and Classification of Members of the Group.
     
    Not applicable.
     
    Item 9.
    Notice of Dissolution of Group.
     
    Not applicable.
     
    Item 10.
    Certifications.
     
    (a) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a–11.
     
    5

    SIGNATURE
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
    Dated:  November 13, 2024
     
     
    JEFFERIES LLC
         
     
    By:
    /s/ Michael J. Sharp
     
     
    Name:
    Michael J. Sharp
     
    Title:
    Executive Vice President, General Counsel and Secretary
         
     
    JEFFERIES FINANCIAL GROUP INC.
         
     
    By:
    /s/ Michael J. Sharp
     
     
    Name:
    Michael J. Sharp
     
    Title:
    Executive Vice President and General Counsel

    6

    EXHIBIT INDEX
     
    Exhibit No.
    Description
       
    1
    Joint Filing Agreement by and among the Reporting Persons


    7

    Get the next $AHCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AHCO

    DatePrice TargetRatingAnalyst
    1/8/2024$14.50 → $8.00Buy → Hold
    Jefferies
    11/8/2023$9.50 → $6.50Neutral → Underperform
    BofA Securities
    5/10/2023$28.00 → $11.30Buy → Hold
    Deutsche Bank
    5/10/2023$18.00 → $11.00Buy → Hold
    Stifel
    5/9/2023$21.00 → $12.00Buy → Neutral
    BofA Securities
    3/8/2022$31.00 → $26.00Outperform
    RBC Capital
    3/2/2022$32.00 → $24.00Outperform
    SVB Leerink
    2/18/2022$35.00 → $32.00Outperform
    SVB Leerink
    More analyst ratings

    $AHCO
    Financials

    Live finance-specific insights

    See more
    • AdaptHealth Corp. Announces First Quarter 2025 Results

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2025. First Quarter Results and Highlights All comparisons are to the quarter ended March 31, 2024. Net revenue was $777.9 million compared to $792.5 million, a decrease of 1.8%. Net loss attributable to AdaptHealth Corp. was $7.2 million compared to net loss of $2.1 million. Adjusted EBITDA was $127.9 million compared to $158.5 million, a decrease of 19.3%. Cash flow from operations was $95.5 mi

      5/6/25 7:00:00 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth Corp. Announces First Quarter 2025 Earnings Release Date and Conference Call

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2025 financial results before the opening of the financial markets on Tuesday, May 6, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-5172 (Domestic) or (203) 518-9856 (International) When prompted, reference Conference ID: AHCO1Q25 Webcast registration: Click Here Following the live

      4/21/25 4:05:00 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth Corp. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2024 financial results before the opening of the financial markets on Tuesday, February 25, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 245-3047 (Domestic) or (203) 518-9765 (International) When prompted, reference Conference ID: AHCO4Q24 Webcast registration: Clic

      2/4/25 4:05:00 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AdaptHealth downgraded by Jefferies with a new price target

      Jefferies downgraded AdaptHealth from Buy to Hold and set a new price target of $8.00 from $14.50 previously

      1/8/24 9:03:40 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth downgraded by BofA Securities with a new price target

      BofA Securities downgraded AdaptHealth from Neutral to Underperform and set a new price target of $6.50 from $9.50 previously

      11/8/23 6:22:25 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded AdaptHealth from Buy to Hold and set a new price target of $11.30 from $28.00 previously

      5/10/23 6:33:54 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

      SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

      11/14/24 9:03:31 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by AdaptHealth Corp.

      SC 13G - AdaptHealth Corp. (0001725255) (Subject)

      11/13/24 9:30:46 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

      SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

      11/12/24 1:30:20 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AdaptHealth Corp. Announces First Quarter 2025 Results

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2025. First Quarter Results and Highlights All comparisons are to the quarter ended March 31, 2024. Net revenue was $777.9 million compared to $792.5 million, a decrease of 1.8%. Net loss attributable to AdaptHealth Corp. was $7.2 million compared to net loss of $2.1 million. Adjusted EBITDA was $127.9 million compared to $158.5 million, a decrease of 19.3%. Cash flow from operations was $95.5 mi

      5/6/25 7:00:00 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth Corp. Announces First Quarter 2025 Earnings Release Date and Conference Call

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2025 financial results before the opening of the financial markets on Tuesday, May 6, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-5172 (Domestic) or (203) 518-9856 (International) When prompted, reference Conference ID: AHCO1Q25 Webcast registration: Click Here Following the live

      4/21/25 4:05:00 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth Corp. to Participate in Upcoming Investor Conferences

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Jefferies Value-Based Healthcare Summit, being held in Miami, on Monday, March 10, 2025, including a fireside chat at 3:45pm ET. The Leerink Partners Global Healthcare Conference 2025, being held in Miami, on Tuesday, March 11, 2025, including a fireside chat at 11:20am ET. The webcast link will be available on the Company's website, www.adapthealth.com under "Investor Relations.

      3/6/25 4:05:00 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Commercial Officer Schuster Iii Russell E. was granted 99,006 shares (SEC Form 4)

      4 - AdaptHealth Corp. (0001725255) (Issuer)

      2/4/25 4:32:22 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • CLO and General Counsel Rew Richard W. Ii was granted 48,409 shares (SEC Form 4)

      4 - AdaptHealth Corp. (0001725255) (Issuer)

      2/4/25 4:30:31 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Chief Technology Officer Prast Albert A. was granted 62,932 shares, increasing direct ownership by 20% to 379,458 units (SEC Form 4)

      4 - AdaptHealth Corp. (0001725255) (Issuer)

      2/4/25 4:29:15 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by AdaptHealth Corp.

      SCHEDULE 13G - AdaptHealth Corp. (0001725255) (Subject)

      5/15/25 9:33:34 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by AdaptHealth Corp.

      SCHEDULE 13G/A - AdaptHealth Corp. (0001725255) (Subject)

      5/12/25 10:24:40 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by AdaptHealth Corp.

      10-Q - AdaptHealth Corp. (0001725255) (Filer)

      5/6/25 4:29:45 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    Leadership Updates

    Live Leadership Updates

    See more
    • AdaptHealth Corp. Announces Appointment of Russell Schuster as Chief Commercial Officer

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Russell Schuster has been appointed Chief Commercial Officer, effective December 2nd, 2024. In his new role, Mr. Schuster will oversee commercial strategy and revenue generation for the Company. He is a seasoned executive with more than 25 years of experience and a proven track record of growing large businesses. Most recently, Mr. Schuster served as President of Cardinal Health Canada, where he delivered meaningful performance improvement. Over eight ye

      12/3/24 8:00:00 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth Appoints Diana Nole to Board of Directors

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. "We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology sector caught our eye and we soon discovered that her decisive, resourceful leadership style and expertise in business transformation aligned perfectly with our current goals as an organization," said Dale Wolf, Chairman of the AdaptHealth B

      10/17/24 8:00:00 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer

      Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024. Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served

      9/25/24 11:19:00 AM ET
      $AHCO
      $LH
      Medical/Nursing Services
      Health Care
      Medical Specialities